CardioVasc Advantage(TM) Vascular Reconstruction Device now cleared for marketing in Europe PALO ALTO, Calif., Aug. 12 (HSMN NewsFeed) — Nfocus Neuromedical Inc. announced today that its CardioVasc Advantage(TM) Vascular Reconstruction Device has bee…
Devices, Interventional, Regulatory
Nfocus Neuromedical, CardioVasc Advantage, Vascular Reconstruction

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Nfocus Neuromedical Obtains CE Approval for New Vascular Reconstruction Device”
Leave a Comment